Tailoring transfusion strategy using thromboelastogram in goal-directed massive transfusion: Impact on transfusion requirements and clinical outcomes
Open Access
- 1 January 2024
- journal article
- research article
- Published by Medknow in Asian Journal of Transfusion Science
- Vol. 18 (1) , 7-15
Abstract
BACKGROUND AND OBJECTIVE: We compared the overall clinical outcome in formula-based protocol (1:1:1) and thromboelastogram (TEG)-guided goal-based massive transfusion (MT) in the resuscitation of patients with hemorrhagic shock. MATERIALS AND METHODS: This was a retro-prospective case–control study conducted over a period of 2 years among the patients who received MT using a 1:1:1 fixed ratio protocol (controls, Group A) and goal-based protocol (cases, Group B) guided through TEG. Patients were matched for the type and severity of the clinical conditions. Utilization of blood components, clinical outcomes, transfusion-related complications, and total mortality rates were compared between the groups. RESULTS: There were 113 patients in the formula-based group and 109 patients in the goal-based transfusion group who were matched for injury severity scores. The total blood components utilized were 1867 and 1560, respectively, with a 17.7% reduction associated with the use of TEG. Patients were divided into normal, hypo, and hypercoagulable based on TEG, and a higher transfusion rate was associated with hypocoagulable TEG (942 vs. 610). The prothrombin time, activated partial thromboplastin time, R time, and K time had a significant positive correlation with the need to transfuse more than 20 blood components, whereas platelet count, base excess, alpha angle, MA, and CI had a negative correlation (r = 0.268, P < 0.001). At the end of goal-directed transfusion, 75% of the patients were free of transfusion support (vs. 65.4%) and only 6.9% of the patients had coagulopathy (vs. 31.8%) compared to formula-based resuscitation with a 10% reduction in mortality. CONCLUSION: TEG-guided goal-based approach helped to reduce blood component utilization with a reduced incidence of coagulopathy at the end of the MT while improving patient survival.Keywords
This publication has 28 references indexed in Scilit:
- Pathophysiology of Trauma-Induced CoagulopathyTransfusion Medicine Reviews, 2021
- The Complexity of Trauma-Induced CoagulopathySeminars in Thrombosis and Hemostasis, 2020
- Traumatic-Induced Coagulopathy as a Systems Failure: A New Window into HemostasisSeminars in Thrombosis and Hemostasis, 2020
- Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic ReviewTransfusion Medicine Reviews, 2018
- Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trialThe Lancet, 2017
- Fibrinogen concentrates for post-partum haemorrhage? Do not miss the most relevant population!British Journal of Anaesthesia, 2015
- Update on massive transfusionBritish Journal of Anaesthesia, 2013
- Postpartum hemorrhage and low fibrinogen levels: the past, present and futureInternational Journal of Obstetric Anesthesia, 2013
- The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) StudyJAMA Surgery, 2013
- Coagulation Abnormalities in the Trauma Patient: The Role of Point-of-Care ThromboelastographySeminars in Thrombosis and Hemostasis, 2010